Cargando…
Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods
The use of small animal models for the study of infectious disease is critical for understanding disease progression and for developing prophylactic and therapeutic treatment options. For many diseases, Syrian golden hamsters have emerged as an ideal animal model due to their low cost, small size, e...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121384/ https://www.ncbi.nlm.nih.gov/pubmed/27722960 http://dx.doi.org/10.1007/5584_2016_135 |
_version_ | 1783515190695821312 |
---|---|
author | Warner, Bryce M. Safronetz, David Kobinger, Gary P. |
author_facet | Warner, Bryce M. Safronetz, David Kobinger, Gary P. |
author_sort | Warner, Bryce M. |
collection | PubMed |
description | The use of small animal models for the study of infectious disease is critical for understanding disease progression and for developing prophylactic and therapeutic treatment options. For many diseases, Syrian golden hamsters have emerged as an ideal animal model due to their low cost, small size, ease of handling, and ability to accurately reflect disease progression in humans. Despite the increasing use and popularity of hamsters, there remains a lack of available reagents for studying hamster immune responses. Without suitable reagents for assessing immune responses, researchers are left to examine clinical signs and disease pathology. This becomes an issue for the development of vaccine and treatment options where characterizing the type of immune response generated is critical for understanding protection from disease. Despite the relative lack of reagents for use in hamsters, significant advances have been made recently with several hamster specific immunologic methods being developed. Here we discuss the progress of this development, with focus on classical methods used as well as more recent molecular methods. We outline what methods are currently available for use in hamsters and what is readily used as well as what limitations still exist and future perspectives of reagent and assay development for hamsters. This will provide valuable information to researchers who are deciding whether to use hamsters as an animal model. |
format | Online Article Text |
id | pubmed-7121384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71213842020-04-06 Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods Warner, Bryce M. Safronetz, David Kobinger, Gary P. Emerging and Re-emerging Viral Infections Article The use of small animal models for the study of infectious disease is critical for understanding disease progression and for developing prophylactic and therapeutic treatment options. For many diseases, Syrian golden hamsters have emerged as an ideal animal model due to their low cost, small size, ease of handling, and ability to accurately reflect disease progression in humans. Despite the increasing use and popularity of hamsters, there remains a lack of available reagents for studying hamster immune responses. Without suitable reagents for assessing immune responses, researchers are left to examine clinical signs and disease pathology. This becomes an issue for the development of vaccine and treatment options where characterizing the type of immune response generated is critical for understanding protection from disease. Despite the relative lack of reagents for use in hamsters, significant advances have been made recently with several hamster specific immunologic methods being developed. Here we discuss the progress of this development, with focus on classical methods used as well as more recent molecular methods. We outline what methods are currently available for use in hamsters and what is readily used as well as what limitations still exist and future perspectives of reagent and assay development for hamsters. This will provide valuable information to researchers who are deciding whether to use hamsters as an animal model. 2016-10-09 /pmc/articles/PMC7121384/ /pubmed/27722960 http://dx.doi.org/10.1007/5584_2016_135 Text en © Springer International Publishing Switzerland 2016 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Warner, Bryce M. Safronetz, David Kobinger, Gary P. Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods |
title | Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods |
title_full | Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods |
title_fullStr | Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods |
title_full_unstemmed | Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods |
title_short | Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods |
title_sort | syrian hamsters as a small animal model for emerging infectious diseases: advances in immunologic methods |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121384/ https://www.ncbi.nlm.nih.gov/pubmed/27722960 http://dx.doi.org/10.1007/5584_2016_135 |
work_keys_str_mv | AT warnerbrycem syrianhamstersasasmallanimalmodelforemerginginfectiousdiseasesadvancesinimmunologicmethods AT safronetzdavid syrianhamstersasasmallanimalmodelforemerginginfectiousdiseasesadvancesinimmunologicmethods AT kobingergaryp syrianhamstersasasmallanimalmodelforemerginginfectiousdiseasesadvancesinimmunologicmethods |